Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.

Hyaluronan-binding sites were demonstrated on the cell surface of three malignant mesothelioma cell lines derived from human tumors using either [3H]hyaluronan or fluorescein-tagged hyaluronan. No hyaluronan-binding activity was observed on normal human mesothelial cells. The absence of hyaluronan receptors on normal human mesothelial cells was not due to a down-regulation by endogenously synthesized hyaluronan, since no binding sites appeared when the cells were cultured under conditions known to suppress hyaluronan synthesis (in starvation medium containing either hydrocortisone or n-butyrate) or to degrade endogenously synthesized hyaluronan (in the presence of Streptomyces or testicular hyaluronidase). The binding of [3H]hyaluronan on mesothelioma cells could be partially inhibited by prior incubation of the cells with trypsin, indicating that the hyaluronan-binding site is a protein. The binding sites on human malignant mesothelioma cells were shown to be saturable with about 54,000 hyaluronan molecules (M(r) 1.4 x 10(6)) bound per cell with a Kd of 0.3 x 10(-9) M. The binding was specific for hyaluronan inasmuch as a number of other macromolecules gave negligible inhibition of the binding. High molecular weight preparations of hyaluronan inhibited the binding more effectively than low molecular weight preparations; hyaluronan oligosaccharides down to a length of six monosaccharide units showed competing activity. The hyaluronan receptor appeared to be related to CD44 (a cell surface glycoprotein previously suggested to function as a hyaluronan receptor) since Hermes-1 monoclonal antibodies which inhibit the binding of hyaluronan to CD44 blocked a major part of the binding of hyaluronan to the mesothelioma cells. However, there was no strict correlation between the hyaluronan-binding activity on the mesothelioma cell lines tested and the levels of CD44 molecules on their cell surface, suggesting that only a subfraction of the CD44 molecules bound hyaluronan or that other hyaluronan-binding proteins also exist on those cells. The presence of hyaluronan receptors on mesothelioma cells, but not on their normal counterparts, may be of importance for the migration of the transformed cells in hyaluronan-enriched matrices and for their ability to form metastases.

[1]  E. Turley,et al.  TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan , 1993, The Journal of cell biology.

[2]  P. Heldin,et al.  Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. , 1993, Experimental cell research.

[3]  W. Knudson,et al.  Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. , 1993, Journal of cell science.

[4]  P. Kincade,et al.  Antibody‐induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody , 1993, European journal of immunology.

[5]  P. Herrlich,et al.  Prevention of tumor metastasis formation by anti-variant CD44 , 1993, The Journal of experimental medicine.

[6]  P. Heldin,et al.  Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. , 1993, Cancer research.

[7]  C. Underhill,et al.  CD44: the hyaluronan receptor. , 1992, Journal of cell science.

[8]  R. Hyman,et al.  CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells , 1992, European journal of immunology.

[9]  D. Nance,et al.  Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility [published erratum appears in J Cell Biol 1992 Aug;118(3):753] , 1992, The Journal of cell biology.

[10]  P. Heldin,et al.  Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells. , 1992, The Biochemical journal.

[11]  L. Klareskog,et al.  Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells. A role for macrophage-derived factors. , 1992, Arthritis and rheumatism.

[12]  J. Bell,et al.  Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. , 1992, The Journal of biological chemistry.

[13]  M. Culty,et al.  The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan , 1992, The Journal of cell biology.

[14]  P. Weigel,et al.  Detergent solubilization of the endocytic Ca(2+)-independent hyaluronan receptor from rat liver endothelial cells and separation from a Ca(2+)-dependent hyaluronan-binding activity. , 1992, Biochemistry.

[15]  I. Stamenkovic,et al.  Distinct effects of two CD44 isoforms on tumor growth in vivo , 1991, The Journal of experimental medicine.

[16]  H. Liao,et al.  The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. , 1991, Cancer cells.

[17]  M. Amiot,et al.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.

[18]  B. Toole Hyaluronan and its binding proteins, the hyaladherins. , 1990, Current opinion in cell biology.

[19]  K. Miyake,et al.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.

[20]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[21]  E. Turley,et al.  A hyaluronan-binding protein shows a partial and temporally regulated codistribution with actin on locomoting chick heart fibroblasts. , 1990, Experimental cell research.

[22]  S. Holland,et al.  The cDNA sequence of mouse Pgp-1 and homology to human CD44 cell surface antigen and proteoglycan core/link proteins. , 1990, The Journal of biological chemistry.

[23]  C. Underhill The interaction of hyaluronate with the cell surface: the hyaluronate receptor and the core protein. , 2007, Ciba Foundation symposium.

[24]  E. Turley The role of a cell-associated hyaluronan-binding protein in fibroblast behaviour. , 1989, Ciba Foundation symposium.

[25]  H. Hoogsteden,et al.  Establishment of human malignant mesothelioma cell lines , 1989, International journal of cancer.

[26]  B. Risberg,et al.  Increased lymphatic elimination of interstitial hyaluronan during E. coli sepsis in sheep. , 1989, The American journal of physiology.

[27]  C. Underhill,et al.  The hyaluronate receptor is preferentially expressed on proliferating epithelial cells , 1989, The Journal of cell biology.

[28]  L. Picker,et al.  A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins , 1989, Cell.

[29]  Brian Seed,et al.  A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family , 1989, Cell.

[30]  C. Heldin,et al.  Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. , 1989, The Biochemical journal.

[31]  B. Toole,et al.  The role and regulation of tumour-associated hyaluronan. , 1989, Ciba Foundation symposium.

[32]  R. Mason,et al.  Hyaluronan and hyaluronan-binding proteins in cartilaginous tissues. , 1989, Ciba Foundation symposium.

[33]  P. Weigel,et al.  The specific interaction between fibrin(ogen) and hyaluronan: possible consequences in haemostasis, inflammation and wound healing. , 1989, Ciba Foundation symposium.

[34]  P. Weigel,et al.  Affinity and distribution of surface and intracellular hyaluronic acid receptors in isolated rat liver endothelial cells. , 1988, The Journal of biological chemistry.

[35]  M. Klockars,et al.  Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. , 1988, Chest.

[36]  T. Waaler,et al.  Limiting viscosity number and weight average molecular weight of hyaluronate samples produced by heat degradation , 1988 .

[37]  T. Laurent,et al.  Concentration of hyaluronan in the serum of untreated cancer patients with special reference to patients with mesothelioma , 1988, Cancer.

[38]  G. Tarone,et al.  Distribution of hyaluronate and hyaluronate receptors in the adult lung. , 1988, Journal of cell science.

[39]  B. Toole,et al.  The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells. , 1987, Biochemical and biophysical research communications.

[40]  P. Comoglio,et al.  The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. , 1987, The Journal of biological chemistry.

[41]  B. E. Lacy,et al.  The hyaluronate receptor is associated with actin filaments , 1987, The Journal of cell biology.

[42]  J. R. de los Toyos,et al.  Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells , 1987, The Journal of cell biology.

[43]  T. Smith n-Butyrate inhibition of hyaluronate synthesis in cultured human fibroblasts. , 1987, The Journal of clinical investigation.

[44]  A. Engström‐Làurent,et al.  Urinary excretion of hyaluronan in man. , 1987, Scandinavian journal of clinical and laboratory investigation.

[45]  S. Jalkanen,et al.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man , 1986, European journal of immunology.

[46]  B. E. Lacy,et al.  Characterization and identification of the hyaluronate binding site from membranes of SV-3T3 cells. , 1985, The Journal of biological chemistry.

[47]  J. Roboz,et al.  Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. , 1985, Cancer research.

[48]  B. Smedsrød,et al.  Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. , 1984, The Biochemical journal.

[49]  B. Toole,et al.  Endogenous hyaluronate-cell surface interactions in 3T3 and simian virus-transformed 3T3 cells. , 1984, The Journal of biological chemistry.

[50]  N. Connell,et al.  Regulation of the cytoskeleton in mesothelial cells: Reversible loss of keratin and increase in vimentin during rapid growth in culture , 1983, Cell.

[51]  T. Laurent,et al.  Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. , 1981, The Biochemical journal.

[52]  B. Toole Glycosaminoglycans in Morphogenesis , 1981 .

[53]  A. Tengblad,et al.  Quantitative analysis of hyaluronate in nanogram amounts. , 1980, The Biochemical journal.

[54]  B. Toole,et al.  Binding of hyaluronate to the surface of cultured cells , 1979, The Journal of cell biology.

[55]  K. O. Wik,et al.  Preparation and properties of fluorescein-labelled hyaluronate. , 1975, Carbohydrate research.

[56]  Å. Wasteson Properties of fractionated chondroitin sulphate from ox nasal septa. , 1971, The Biochemical journal.

[57]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.